Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorUniversity of Trieste
About this trial
Chronic obstructive pulmonary disease (COPD) exacerbations are risk factors for disease progression and short-term re- hospitalizations. We propose a randomized controlled trial to evaluate the efficacy of a one-device multiparameter telemonitoring in reducing functional decline, symptoms, and risk of re-hospitalization of patients discharged after hospitalization for exacerbated COPD.
Eligibility criteria
Qualifiers
Able to understand and sign the informed consent form.
Already established diagnosis of COPD according to Global Initiative for Obstructive Lung Disease (GOLD) guidelines.[13]
Diagnosis of COPD exacerbation at admission, according to GOLD guidelines.[13]
Arterial partial pressure of oxygen (PaO2) < 60 mmHg in ambient air at rest at admission and arterial partial pressure of oxygen (PaO2) > 60 mmHg in ambient air at rest at discharge, if not on long-term oxygen therapy on ventilation.
Disqualifiers
Heart failure as the main cause of acute respiratory failure
Acute pulmonary embolism/chronic pulmonary thromboembolism
Interstitial lung disease as the main cause of acute respiratory failure
Pneumonia as the main cause of acute respiratory failure
Trial design
Treatments tested in this trial
- Telemonitoring
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov